Last reviewed · How we verify
Sci-B-Vac-Lot B
Sci-B-Vac-Lot B is a vaccine that stimulates an immune response against the hepatitis B virus.
Sci-B-Vac-Lot B is a vaccine that stimulates an immune response against the hepatitis B virus. Used for Prevention of hepatitis B infection.
At a glance
| Generic name | Sci-B-Vac-Lot B |
|---|---|
| Also known as | Sci-B-Vac, 3-antigen HepB Vaccine, Bio-Hep-B |
| Sponsor | VBI Vaccines Inc. |
| Drug class | vaccine |
| Modality | Biologic |
| Therapeutic area | Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
It works by introducing a piece of the hepatitis B virus to the body, which triggers an immune response and helps the body produce antibodies to fight the virus. This immune response can provide long-term protection against hepatitis B infection.
Approved indications
- Prevention of hepatitis B infection
Common side effects
- Injection site pain
- Fatigue
- Headache
Key clinical trials
- A Bridging Study: Comparing Two Lots of Sci-B-Vac™ and Engerix-B in Healthy Adults (PHASE3)
- Lot-to-lot Consistency of Sci-B-Vac™ in Adults (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |